论文信息 - 524PBevacizumab first line and impact on subsequent anti-EGFR activity - 字舞流文

524PBevacizumab first line and impact on subsequent anti-EGFR activity

D. Roder | C. Karapetis | T. Price | R. Padbury | M. burge | J. Hardingham | A. Townsend | A. Roy | Eric Smith